About
Filing in additional markets
Areas of Focus
Categories
Hawaii, Alaska, Puerto Rico
Team (11)
Clinical Trials (39)
View allTotal Trials
39
As Lead Sponsor
19
As Collaborator
20
Total Enrollment
7,236
By Phase
PHASE1/PHASE2: 8PHASE1: 2PHASE4: 8NA: 1PHASE2: 9PHASE3: 4
By Status
COMPLETED: 30TERMINATED: 4UNKNOWN: 3WITHDRAWN: 2
Clinical Trials Pipeline39 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT03687125Lead Sponsor
Tinostamustine Conditioning and Autologous Stem Cell
PHASE1/PHASE2Terminated
6 participants
Started: Oct 15, 2018 · Completed: Apr 17, 2019
NCT04279938Collaborator
A Phase Ib Combination Study of Rituximab, TinostamustinEAnd CHeckpoint Inhibition With Pembrolizumab in Relapsed/Refractory DLBCL
PHASE1Withdrawn
Started: Sep 30, 2018 · Completed: Jan 31, 2021
NCT03798899Lead Sponsor
Efficacy and Safety of Penthrox® Combined With a Standard Analgesia (SoC) in Adult Patients Admitted to the Emergency Department With Moderate to Severe Pain Associated With Trauma
PHASE4Completed
360 participants
Started: May 14, 2018 · Completed: Dec 20, 2018
NCT03380247Collaborator
Multimodal Oral Analgesia for Trauma in the Emergency Department
N/ACompleted
200 participants
Started: Oct 12, 2017 · Completed: Jul 6, 2018
NCT02863263Lead Sponsor
Efficacy and Safety of MedifoamⓇ and BetafoamⓇ in Pressure Ulcer
NATerminated
5 participants
Started: Jul 29, 2016 · Completed: Jul 26, 2017
Locations (1)
Headquarters
Cambridge, UK
Map
Loading map...